Nucleic Acid Therapeutics Market Key Players Analysis - Novartis, Moderna Inc, BioNTech, Arrowhead Pharmaceuticals, Merck, Thermo Fischer Scientific.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nucleic Acid Therapeutics Market - (By Technology (RNA targeted therapeutics, Gene Therapies, Epigenetic and microRNA modulating therapies, Genome editing therapies, Others), By Application (Autoimmune Disorders, Genetic Disorders, Infectious Diseases, Cancer, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Nucleic Acid Therapeutics Market is valued at US$ 4.93 billion in 2023, and it is expected to reach US$ 13.86 billion by 2031, with a CAGR of 13.8% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2548

Nucleic acid therapeutics encompass a range of medical treatments that utilize therapeutic nucleic acids, such as DNA and RNA, to treat or prevent diseases. The market is poised for substantial growth, driven by increased research initiatives aimed at enhancing healthcare systems globally in response to the rising prevalence of chronic diseases and genetic disorders. Moreover, the growing demand for pharmaceuticals and healthcare services, coupled with advancements in biological products and DNA-based therapies, is contributing to the expansion of the nucleic acid therapeutics industry.

Despite these positive trends, several challenges are expected to impede market growth. High costs associated with nucleic acid therapies, a shortage of skilled professionals, and the use of outdated technologies are anticipated to limit the market's potential. However, the increasing adoption of personalized medicine, which involves developing patient-specific treatments based on genetic profiles, is driving further interest in nucleic acid therapeutics. Additionally, heightened focus from pharmaceutical companies on developing nucleic acid-based treatments, along with faster market absorption, increasing product demand, and a thriving global market, are key factors expected to propel market growth in the coming years.

List of Prominent Players in the Nucleic Acid Therapeutics Market:
• Novartis
• Moderna Inc
• BioNTech
• Arrowhead Pharmaceuticals
• Merck
• Thermo Fischer Scientific
• Sanofi
• Alnylam Pharmaceuticals
• Sarepta Therapeutics
• Qiagen
• Imugene
• Copernicus Therapeutics Inc.
• Protagonist Therapeutics
• Arbutus Biopharma
• Agilent Technologies
• Silence Therapeutics (UK),
• Astellas Pharma Inc. (Japan),
• CureVac SE (Germany),
• Sirnaomics (US),
• Arcturus Therapeutics Inc. (US)
• Other Market Players

Market Dynamics:
Drivers-
The growing prevalence of genetic disorders, such as cystic fibrosis, muscular dystrophy, and various forms of cancer, which are often challenging to treat, is driving the demand for nucleic acid therapeutics. The accelerated pace of drug discovery and development is supported by significant investments in research and development from pharmaceutical companies, government agencies, and academic institutions. Additionally, government initiatives aimed at promoting drug development have streamlined the regulatory approval process and established favorable conditions, which are expected to further support market growth in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Challenges
The growth of the nucleic acid therapeutics market is hindered by the high costs associated with development and production, which limit patient access to these therapies due to their substantial price. Furthermore, the complex nature of nucleic acid therapies presents significant technological challenges, while new treatments face difficulties entering the market due to rigorous approval processes and stringent regulatory requirements. Additionally, limited awareness among healthcare professionals and the general public regarding these advanced treatments poses a barrier to market expansion.

Regional Trends
North America is anticipated to hold a dominant share of the nucleic acid therapeutics market in terms of revenue, with a strong projected compound annual growth rate (CAGR) in the coming years. This growth is driven by the increasing prevalence of chronic diseases such as diabetes and cancer, rising demand for targeted and personalized treatments, and supportive government initiatives. Similarly, Europe holds a significant market share, supported by increased funding for research and development, which has facilitated advancements in gene therapy and addressed the growing incidence of specific diseases. Moreover, factors such as rising disposable income, expanding population, and improvements in healthcare infrastructure are further contributing to market growth in this region.

Recent Developments:
• In April 2024, Arrowhead Pharmaceuticals, Inc. announced the dosing of its investigational RNA interference (RNAi) therapeutic, ARO-CFB, in a Phase 1/2a clinical trial. The trial included up to sixty-six healthy volunteers and patients with complement-mediated kidney disease.
• In Aug 2022, Merck and Orna Therapeutics entered into a collaboration agreement to jointly explore, create, and market various initiatives, such as vaccines and treatments, in the fields of infectious disease and oncology.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2548

Segmentation of Nucleic Acid Therapeutics Market-
By Technology-
• RNA Targeted Therapeutics
• Gene Therapies
• Epigenetic and microRNA Modulating Therapies
• Genome Editing Therapies
• Others
By Application-
• Autoimmune Disorders
• Genetic Disorders
• Infectious Diseases
• Cancer
• Others
By End-User-
• Hospitals & Clinics
• Academic & Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.